<?xml version="1.0" encoding="UTF-8"?>
<p>Cyclosporine, a non-steroidal immunomodulatory, was first developed in the 1970s as a novel drug to inhibit T cells both specifically and reversibly. Its first use was in whole organ transplants in attempts to avoid transplant rejection by tempering the hostâ€™s own immune response.
 <xref rid="CIT0077" ref-type="bibr">77</xref> Ocular use in HAdV keratoconjunctivitis should be considered when there is a need to dampen the immune response as in corneal complications of the virus, especially when there are contraindications of using corticosteroids or to limit associated corticosteroid complications.
</p>
